IDH2 and oligodendroglioma: According to the 2021 WHO CNS classification guidelines, oligodendrogliomas are molecularly characterized by mutations in the isocitrate dehydrogenase (IDH) and the co-deletion of chromosome arms 1p and 19q [2,8].